Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 165, Issue -, Pages 115179
Publisher
Elsevier BV
Online
2023-07-21
DOI
10.1016/j.biopha.2023.115179
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2023
- (2023) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Emerging Epigenetic‐Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment
- (2023) Jiaxin Zhang et al. Advanced Science
- FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer
- (2023) Yifan Liu et al. Journal of Translational Medicine
- Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies
- (2022) Nisha Kumari et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Development of Pharmaceutical Nanomedicines: From the Bench to the Market
- (2022) Abdulrahman A. Halwani Pharmaceutics
- Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming
- (2022) Ting Zhao et al. Acta Biomaterialia
- Smart hypoxia-responsive transformable and charge-reversible nanoparticles for the deep penetration and tumor microenvironment modulation of pancreatic cancer
- (2022) Hongyi Chen et al. BIOMATERIALS
- Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma
- (2022) Philip A. Philip et al. CLINICAL CANCER RESEARCH
- Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?
- (2022) Stavros P. Papadakos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer
- (2022) Rom Leidner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ
- (2022) Yi Liu et al. Nature Communications
- Current approaches of nanomedicines in the market and various stage of clinical translation
- (2022) Xiaoting Shan et al. Acta Pharmaceutica Sinica B
- Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment
- (2022) Muhammad R. Haque et al. Microsystems & Nanoengineering
- Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma
- (2022) Biaoming Xu et al. INTERNATIONAL JOURNAL OF CANCER
- Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2022) Hedy L. Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
- (2022) Ying Zhang et al. JOURNAL OF NANOBIOTECHNOLOGY
- Nanomedicine Penetration to Tumor: Challenges, and Advanced Strategies to Tackle This Issue
- (2022) Muhammad Usman Munir Cancers
- Editorial: The Microenvironment in Pancreatic Cancer and Therapeutic Strategies Targeting Microenvironment
- (2022) Wanxing Duan et al. Frontiers in Oncology
- Challenging the fundamental conjectures in nanoparticle drug delivery for chemotherapy treatment of solid cancers
- (2022) Juanjuan Yang et al. ADVANCED DRUG DELIVERY REVIEWS
- Vascularized pancreas-on-a-chip device produced using a printable simulated extracellular matrix
- (2022) Monika Hospodiuk-Karwowski et al. Biomedical Materials
- Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry
- (2022) Jordan Santucci et al. EUROPEAN JOURNAL OF CANCER
- Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies
- (2022) Hailong Tian et al. Journal of Hematology & Oncology
- Stromal Homeostasis-Restoring Nanomedicine Enhances Pancreatic Cancer Chemotherapy
- (2022) Na Yu et al. NANO LETTERS
- Tumor Microenvironment-Based Stimuli-Responsive Nanoparticles for Controlled Release of Drugs in Cancer Therapy
- (2022) Weixin Zhou et al. Pharmaceutics
- Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy
- (2022) Wanting Hou et al. Pharmaceutics
- Liposome-based diagnostic and therapeutic applications for pancreatic cancer
- (2022) Faisal Raza et al. Acta Biomaterialia
- PDAC-on-chip for in vitro modeling of stromal and pancreatic cancer cell crosstalk
- (2022) Viola Sgarminato et al. Biomaterials Science
- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A MET Targeting Antibody-Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic Cancer
- (2021) Alex Cazes et al. CLINICAL CANCER RESEARCH
- Ex vivo culture of intact human patient derived pancreatic tumour tissue
- (2021) John Kokkinos et al. Scientific Reports
- The CXCL12 Crossroads in Cancer Stem Cells and Their Niche
- (2021) Juan Carlos López-Gil et al. Cancers
- pH-Sensitive Nanoparticles Composed Solely of Membrane-Disruptive Macromolecules for Treating Pancreatic Cancer
- (2021) Feng Fan et al. ACS Applied Materials & Interfaces
- KRAS drives immune evasion in a genetic model of pancreatic cancer
- (2021) Irene Ischenko et al. Nature Communications
- The Revolutionary Roads to Study Cell–Cell Interactions in 3D In Vitro Pancreatic Cancer Models
- (2021) Donatella Delle Cave et al. Cancers
- Smart transformable nanomedicines for cancer therapy
- (2021) Yuequan Wang et al. BIOMATERIALS
- Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy
- (2021) Iris Lodewijk et al. Clinical Epigenetics
- Penetration Cascade of Size Switchable Nanosystem in Desmoplastic Stroma for Improved Pancreatic Cancer Therapy
- (2021) Xiaozheng Zhao et al. ACS Nano
- Modeling pancreatic cancer in mice for experimental therapeutics
- (2021) Kavita Mallya et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Gain-of-function p53R172H mutation drives accumulation of neutrophils in pancreatic tumors, promoting resistance to immunotherapy
- (2021) Despina Siolas et al. Cell Reports
- Organ-Chip Models: Opportunities for Precision Medicine in Pancreatic Cancer
- (2021) Muhammad R. Haque et al. Cancers
- Targeting the Stroma in the Management of Pancreatic Cancer
- (2021) Penelope Edwards et al. Frontiers in Oncology
- Reduction-responsive RNAi nanoplatform to reprogram tumor lipid metabolism and repolarize macrophage for combination pancreatic cancer therapy
- (2021) Shuwen Cao et al. BIOMATERIALS
- Hybrid artificial cell-mediated epigenetic inhibition in metastatic lung cancer
- (2021) Qingsheng Peng et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
- (2021) Enyong Dai et al. Molecular Cancer
- Hyaluronic acid nanoparticle-encapsulated microRNA-125b repolarizes tumor-associated macrophages in pancreatic cancer
- (2021) Neha N Parayath et al. Nanomedicine
- Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology
- (2021) David Osuna de la Peña et al. Nature Communications
- Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy
- (2021) Ming Jia et al. JOURNAL OF NANOBIOTECHNOLOGY
- Artificial exosomes mediated spatiotemporal-resolved and targeted delivery of epigenetic inhibitors
- (2021) Huan Li et al. JOURNAL OF NANOBIOTECHNOLOGY
- Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance
- (2021) Michelle K. Greene et al. Cancers
- CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target
- (2021) Shivani Malik et al. Cancers
- Pancreatic Ductal Adenocarcinoma: Preclinical in vitro and ex vivo Models
- (2021) Beate Gündel et al. Frontiers in Cell and Developmental Biology
- Microfluidic Platforms for High-Throughput Pancreatic Ductal Adenocarcinoma Organoid Culture and Drug Screening
- (2021) Marlene Geyer et al. Frontiers in Cell and Developmental Biology
- Epigenetic Therapeutic Strategies to Target Molecular and Cellular Heterogeneity in Pancreatic Cancer
- (2021) Lennart Versemann et al. Visceral Medicine
- Stromal Modulation and Treatment of Metastatic Pancreatic Cancer with Local Intraperitoneal Triple miRNA/siRNA Nanotherapy
- (2020) Ying Xie et al. ACS Nano
- Metformin-Induced Stromal Depletion to Enhance the Penetration of Gemcitabine-Loaded Magnetic Nanoparticles for Pancreatic Cancer Targeted Therapy
- (2020) Haijie Han et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A Biomimetic Tumor Model of Heterogeneous Invasion in Pancreatic Ductal Adenocarcinoma
- (2020) Michael J. Bradney et al. Small
- Magnetic Targeting and Ultrasound Activation of Liposome–Microbubble Conjugate for Enhanced Delivery of Anticancer Therapies
- (2020) Pankaj Dwivedi et al. ACS Applied Materials & Interfaces
- Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer
- (2020) Jingxian Feng et al. BIOMATERIALS
- Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy
- (2020) Qianwen Yu et al. JOURNAL OF CONTROLLED RELEASE
- Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy
- (2020) Man Li et al. JOURNAL OF CONTROLLED RELEASE
- Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
- (2020) Yuanjun Lu et al. Molecular Cancer
- Challenges in nanomedicine clinical translation
- (2020) Josbert M. Metselaar et al. Drug Delivery and Translational Research
- 5-Azacytidine Potentiates Anti-tumor Immunity in a Model of Pancreatic Ductal Adenocarcinoma
- (2020) Nancy D. Ebelt et al. Frontiers in Immunology
- Mucins in pancreatic cancer: A well‐established but promising family for diagnosis, prognosis and therapy
- (2020) Shunda Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix
- (2020) Honglin Jiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulation of pancreatic cancer microenvironment by an intelligent gemcitabine@nanogel system via in vitro 3D model for promoting therapeutic efficiency
- (2020) Di Chen et al. JOURNAL OF CONTROLLED RELEASE
- Targeting the Tumor Core: Hypoxia-Responsive Nanoparticles for the Delivery of Chemotherapy to Pancreatic Tumors
- (2020) Matthew I. Confeld et al. MOLECULAR PHARMACEUTICS
- Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy
- (2020) Bin Tu et al. Frontiers in Cell and Developmental Biology
- Selective tumor antigen vaccine delivery to human CD169+ antigen-presenting cells using ganglioside-liposomes
- (2020) Alsya J. Affandi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aggressive PDACs show hypomethylation of repetitive elements and the execution of an intrinsic IFN program linked to a ductal cell-of-origin
- (2020) Elisa Espinet et al. Cancer Discovery
- Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?
- (2020) Bolun Jiang et al. Frontiers in Oncology
- Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment
- (2020) Wenxi Zhou et al. BIOMATERIALS
- Epigenetics in Breast Cancer Therapy—New Strategies and Future Nanomedicine Perspectives
- (2020) Verona Buocikova et al. Cancers
- Immunostimulatory nanoparticle incorporating two immune agonists for the treatment of pancreatic tumors
- (2020) M.E. Lorkowski et al. JOURNAL OF CONTROLLED RELEASE
- Exosome-based photoacoustic imaging guided photodynamic and immunotherapy for the treatment of pancreatic cancer
- (2020) Yongho Jang et al. JOURNAL OF CONTROLLED RELEASE
- Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis
- (2019) Divya Thomas et al. Molecular Cancer
- Targeted Lipid Nanoemulsions Encapsulating Epigenetic Drugs Exhibit Selective Cytotoxicity on CDH1–/FOXM1+ Triple Negative Breast Cancer Cells
- (2019) Bumjun Kim et al. MOLECULAR PHARMACEUTICS
- Starch nanoparticles for delivery of the histone deacetylase inhibitor CG-1521 in breast cancer treatment
- (2019) Esma Alp et al. International Journal of Nanomedicine
- EZH2 inhibitor GSK126 suppresses anti-tumor immunity by driving production of myeloid-derived suppressor cells
- (2019) Shuo Huang et al. CANCER RESEARCH
- A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients
- (2019) Yasuhiro Fujiwara et al. BRITISH JOURNAL OF CANCER
- TAMing pancreatic cancer: combat with a double edged sword
- (2019) Manendra Babu Lankadasari et al. Molecular Cancer
- Codelivery Nanosystem Targeting the Deep Microenvironment of Pancreatic Cancer
- (2019) Xinli Chen et al. NANO LETTERS
- Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance
- (2019) Gabriele D’Errico et al. ONCOGENE
- Gold Nanoparticle Transforms Activated Cancer-Associated Fibroblasts to Quiescence
- (2019) Md. Nazir Hossen et al. ACS Applied Materials & Interfaces
- Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer
- (2019) Sheema Khan et al. BIOMATERIALS
- Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
- (2019) Denarda Dangaj et al. CANCER CELL
- Nanoenabled Reversal of IDO1-Mediated Immunosuppression Synergizes with Immunogenic Chemotherapy for Improved Cancer Therapy
- (2019) Hua Huang et al. NANO LETTERS
- Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2019) Talia Golan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survey of Clinical Translation of Cancer Nanomedicines—Lessons Learned from Successes and Failures
- (2019) Hongliang He et al. ACCOUNTS OF CHEMICAL RESEARCH
- Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors
- (2019) Assaf Zinger et al. ACS Nano
- A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling
- (2019) Duc-Huy T. Nguyen et al. Science Advances
- Nanodiamond-Mediated Delivery of a G9a Inhibitor for Hepatocellular Carcinoma Therapy
- (2019) Mengjie Gu et al. ACS Applied Materials & Interfaces
- Targeting tumour microenvironment, a FAKtual challenge in pancreatic cancer
- (2019) Ezequiel J Tolosa et al. GUT
- Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
- (2019) Aurelien Marabelle et al. JOURNAL OF CLINICAL ONCOLOGY
- Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
- (2019) Gwen Lomberk et al. Nature Communications
- Exosomal miRNA‐1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer
- (2019) Song Shang et al. Cancer Medicine
- Natural Killer Cell-Derived Exosomal miR-3607-3p Inhibits Pancreatic Cancer Progression by Targeting IL-26
- (2019) Hongwei Sun et al. Frontiers in Immunology
- Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma
- (2018) Vincent P. Groot et al. ANNALS OF SURGERY
- Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy
- (2018) Jun Zhao et al. BIOMATERIALS
- Estimation of clinical trial success rates and related parameters
- (2018) Chi Heem Wong et al. BIOSTATISTICS
- LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
- (2018) Wanqiang Sheng et al. CELL
- Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial
- (2018) Gregory L. Beatty et al. GASTROENTEROLOGY
- Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase
- (2018) Dietrich A. Ruess et al. NATURE MEDICINE
- Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
- (2018) Gwen Lomberk et al. Nature Communications
- DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer
- (2018) Na Luo et al. Nature Communications
- Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine
- (2018) Andrew J Aguirre et al. Cancer Discovery
- Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity
- (2018) David Wang et al. Cell Reports
- Biomimetic nanoparticles delivered hedgehog pathway inhibitor to modify tumour microenvironment and improved chemotherapy for pancreatic carcinoma
- (2018) Ting Jiang et al. Artificial Cells Nanomedicine and Biotechnology
- Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells
- (2018) Sivakumar Vijayaraghavalu et al. Drug Delivery and Translational Research
- Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma
- (2018) Zhi Rong Qian et al. JAMA Oncology
- Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer
- (2018) Karen A. Autio et al. JAMA Oncology
- Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers
- (2018) Limei Shen et al. ACS Nano
- Tumor microenvironment participates in metastasis of pancreatic cancer
- (2018) Bo Ren et al. Molecular Cancer
- Pancreatic cancer stem cells: A state or an entity?
- (2018) Patrick C. Hermann et al. SEMINARS IN CANCER BIOLOGY
- Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options
- (2018) Derya Kabacaoglu et al. Frontiers in Immunology
- Cancer epigenetics and the potential of epigenetic drugs for treating solid tumors
- (2018) Zhenghui Liu et al. Expert Review of Anticancer Therapy
- Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo
- (2018) Deby F. Mardhian et al. JOURNAL OF CONTROLLED RELEASE
- Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
- (2018) Andrew McGuigan et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
- (2018) Brian J. Christmas et al. Cancer Immunology Research
- Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic Plasticity
- (2017) Nai-Ming Chen et al. GASTROENTEROLOGY
- Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
- (2017) Aleksandra Adamska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model
- (2017) WG Singleton et al. International Journal of Nanomedicine
- Pendant HDAC inhibitor SAHA derivatised polymer as a novel prodrug micellar carrier for anticancer drugs
- (2017) Jieni Xu et al. JOURNAL OF DRUG TARGETING
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
- (2017) Sushrut Kamerkar et al. NATURE
- Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma
- (2017) Pascal Syren et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
- (2017) Jianqin Lu et al. Nature Communications
- Efficacy of decitabine-loaded gelatinases-stimuli nanoparticles in overcoming cancer drug resistance is mediated via its enhanced demethylating activity to transcription factor AP-2 epsilon
- (2017) Yi-Dong Hong et al. Oncotarget
- Molecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid-protein hybrid nanoparticles for synergistic combinational chemotherapy
- (2017) Hima Bindu Ruttala et al. Oncotarget
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- Smart Superstructures with Ultrahigh pH-Sensitivity for Targeting Acidic Tumor Microenvironment: Instantaneous Size Switching and Improved Tumor Penetration
- (2016) Hong-Jun Li et al. ACS Nano
- Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation
- (2016) Christopher J. Tape et al. CELL
- Genetics and biology of pancreatic ductal adenocarcinoma
- (2016) Haoqiang Ying et al. GENES & DEVELOPMENT
- The Significance of Ras Activity in Pancreatic Cancer Initiation
- (2016) Craig D. Logsdon et al. International Journal of Biological Sciences
- Identification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography
- (2016) Marie K. Gurka et al. JOURNAL OF CONTROLLED RELEASE
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies
- (2016) Bruno Sainz et al. MEDIATORS OF INFLAMMATION
- EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model
- (2016) Amit Singh et al. Nanomedicine-Nanotechnology Biology and Medicine
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Targeted Co-delivery of PTX and TR3 siRNA by PTP Peptide Modified Dendrimer for the Treatment of Pancreatic Cancer
- (2016) Yang Li et al. Small
- The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer
- (2016) Hai Hu et al. TUMOR BIOLOGY
- Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy
- (2016) J. Incio et al. Cancer Discovery
- Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts
- (2016) Andrew H. Nguyen et al. Oncotarget
- Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer
- (2016) Keisuke Yamamoto et al. Oncotarget
- α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (KrasG12D, and KrasG12D/tp53R270H) mice
- (2016) Raj Kumar Verma et al. Scientific Reports
- Disulfide cross-linked micelles of novel HDAC inhibitor thailandepsin A for the treatment of breast cancer
- (2015) Kai Xiao et al. BIOMATERIALS
- Nanoparticle formulations of histone deacetylase inhibitors for effective chemoradiotherapy in solid tumors
- (2015) Edina C. Wang et al. BIOMATERIALS
- A novel epigenetic mechanism regulating hyaluronan production in pancreatic cancer cells
- (2015) Shiro Kohi et al. CLINICAL & EXPERIMENTAL METASTASIS
- Stromal biology and therapy in pancreatic cancer: a changing paradigm
- (2015) Albrecht Neesse et al. GUT
- The Chromatin-Modifying Enzyme Ezh2 Is Critical for the Maintenance of Regulatory T Cell Identity after Activation
- (2015) Michel DuPage et al. IMMUNITY
- Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells
- (2015) Shi-Yong Li et al. JOURNAL OF CONTROLLED RELEASE
- Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
- (2015) Dongjun Peng et al. NATURE
- Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
- (2015) Pawel K Mazur et al. NATURE MEDICINE
- Design and Evaluation of Tumor-Specific Dendrimer Epigenetic Therapeutics
- (2015) Hong Zong et al. ChemistryOpen
- Pancreatic Cancer Patient Survival Correlates with DNA Methylation of Pancreas Development Genes
- (2015) Michael J. Thompson et al. PLoS One
- Biocompatibility and biodistribution of suberoylanilide hydroxamic acid loaded poly (DL-lactide-co-glycolide) nanoparticles for targeted drug delivery in cancer
- (2014) Renu Sankar et al. BIOMEDICINE & PHARMACOTHERAPY
- Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
- (2014) Andrew D. Rhim et al. CANCER CELL
- Hyaluronic acid-coated solid lipid nanoparticles for targeted delivery of vorinostat to CD44 overexpressing cancer cells
- (2014) Tuan Hiep Tran et al. CARBOHYDRATE POLYMERS
- Lipid based nanocarrier system for the potential oral delivery of decitabine: Formulation design, characterization, ex vivo, and in vivo assessment
- (2014) Yub Raj Neupane et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- MMP-9 Responsive PEG Cleavable Nanovesicles for Efficient Delivery of Chemotherapeutics to Pancreatic Cancer
- (2014) Prajakta S. Kulkarni et al. MOLECULAR PHARMACEUTICS
- α-Mangostin: A Dietary Antioxidant Derived from the Pericarp of Garcinia mangostana L. Inhibits Pancreatic Tumor Growth in Xenograft Mouse Model
- (2013) Bilal Bin Hafeez et al. ANTIOXIDANTS & REDOX SIGNALING
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncogenic Kras-Induced GM-CSF Production Promotes the Development of Pancreatic Neoplasia
- (2012) Yuliya Pylayeva-Gupta et al. CANCER CELL
- KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal Adenocarcinoma
- (2012) Jianhua Ling et al. CANCER CELL
- Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma
- (2012) R. Shakya et al. CANCER RESEARCH
- EZH2 couples pancreatic regeneration to neoplastic progression
- (2012) J. Mallen-St. Clair et al. GENES & DEVELOPMENT
- Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
- (2012) Michael A Jacobetz et al. GUT
- Multistage nanoparticle delivery system for deep penetration into tumor tissue
- (2011) C. Wong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pancreatic cancerDNMT1expression and sensitivity toDNMT1inhibitors
- (2010) Ang Li et al. CANCER BIOLOGY & THERAPY
- Phase III Trial Comparing Paclitaxel Poliglumex (CT-2103, PPX) in Combination with Carboplatin Versus Standard Paclitaxel and Carboplatin in the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer
- (2009) Corey J. Langer et al. Journal of Thoracic Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started